Cargando…

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy

Radical surgical resection remains the only effective treatment for advanced pancreatic cancer. Effective protocols for recovery from post-operative complications that result in high rates of morbidity and mortality are therefore essential. The enhanced recovery after surgery (ERAS) protocol is an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Xiaxing, Cheng, Xi, Huo, Zhen, Shi, Yuan, Jin, Zhijian, Feng, Haoran, Wang, Yue, Wen, Chenlei, Qian, Hao, Zhao, Ren, Qiu, Weihua, Shen, Baiyong, Peng, Chenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564609/ https://www.ncbi.nlm.nih.gov/pubmed/28615506 http://dx.doi.org/10.18632/oncotarget.18092

Ejemplares similares

Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
por: Shi, Yusheng, et al.
Publicado: (2020)

Shen’s Whole-Layer Tightly Appressed Anastomosis Technique for Duct-to-Mucosa Pancreaticojejunostomy in Pancreaticoduodenectomy
por: Zhang, Tian, et al.
Publicado: (2016)

Predicting Selection Preference of Robotic Pancreaticoduodenectomy (RPD) in a Chinese Single Center Population: Development and Assessment of a New Predictive Nomogram
por: Huo, Zhen, et al.
Publicado: (2019)

Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
por: Li, Hongzhe, et al.
Publicado: (2017)

Internal Hernia Following Robotic Assisted Pancreaticoduodenectomy
por: Qin, Kai, et al.
Publicado: (2018)

Robot-Assisted Middle Pancreatectomy for Elderly Patients: Our Initial Experience
por: Zhang, Tian, et al.
Publicado: (2015)

Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma
por: Wang, Xinjing, et al.
Publicado: (2018)

Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study
por: Weng, Yuanchi, et al.
Publicado: (2020)

Preliminary experience of the robot-assisted laparoscopic excision of a retroperitoneal mass: A case report
por: LIU, QIN, et al.
Publicado: (2014)

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
por: Jin, Yangbing, et al.
Publicado: (2021)

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Weng, Yuanchi, et al.
Publicado: (2020)

Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature
por: Sheng, Qingfeng, et al.
Publicado: (2017)

Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective, propensity score‐matched cohort study of 1312 patients
por: Ji, Yuchen, et al.
Publicado: (2022)

mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer
por: Wang, Xinjing, et al.
Publicado: (2016)

Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEER Database
por: Wang, Weishen, et al.
Publicado: (2019)

Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospective randomized controlled trial
por: WANG, Weishen, et al.
Publicado: (2022)

Short‐term outcomes between robot‐assisted and open pancreaticoduodenectomy in patients with high body mass index: A propensity score matched study
por: Li, Jingfeng, et al.
Publicado: (2023)

Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling
por: Cheng, Xi, et al.
Publicado: (2016)

CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species
por: Fu, Zhiping, et al.
Publicado: (2018)

Targeting KRAS(G12V) mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors
por: Ai, Qi, et al.
Publicado: (2023)

GADD45β induction by S-adenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemia-hypoxia
por: Ma, Ding, et al.
Publicado: (2016)

Association between miR34b/c Polymorphism rs4938723 and Cancer Risk: A Meta-Analysis of 11 Studies including 6169 Cases and 6337 Controls
por: Wang, Xinjing, et al.
Publicado: (2014)

Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery
por: Zhan, Qian, et al.
Publicado: (2013)

Systematic Review and Meta-Analysis of Pancreatic Amylase Value on Postoperative Day 1 After Pancreatic Resection to Predict Postoperative Pancreatic Fistula
por: Lu, Xiongxiong, et al.
Publicado: (2016)

The impact of Omicron pandemic and COVID‐19 vaccination on the pancreatic adenocarcinoma patients
por: Fu, Ningzhen, et al.
Publicado: (2022)

NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells
por: Zhu, Yi, et al.
Publicado: (2015)

The Immunohistochemical Evaluation of Solid Pseudopapillary Tumors of the Pancreas and Pancreatic Neuroendocrine Tumors Reveals ERO1Lβ as a New Biomarker
por: Xie, Junjie, et al.
Publicado: (2016)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study
por: Zou, Siyi, et al.
Publicado: (2022)

A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of Cholangiocarcinoma
por: Shi, Yuan, et al.
Publicado: (2013)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
por: Shi, Yusheng, et al.
Publicado: (2021)

Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1
por: Lin, Jiewei, et al.
Publicado: (2022)

A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy
por: Wang, Yue, et al.
Publicado: (2019)

The Role of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
por: Jabłońska, Beata, et al.
Publicado: (2020)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
por: Chen, Haoda, et al.
Publicado: (2021)

The Safety and Feasibility of Enhanced Recovery after Surgery in Patients Undergoing Pancreaticoduodenectomy: An Updated Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2020)

FGFR3(△7–9) promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma
por: Jin, Zhijian, et al.
Publicado: (2020)

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma
por: Wen, Chenlei, et al.
Publicado: (2020)

Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma
por: Li, Hongzhe, et al.
Publicado: (2017)

H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma
por: Chen, Shi, et al.
Publicado: (2014)

Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer
por: Lin, Jiewei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67au83sujqkl2rf3povggipctm